Skip to content
The Executives BriefThe Executives BriefBeta

Lorde dumps 49 Virgin session demos on XRAYS, turning a pop anniversary into a studio teardown

Her XRAYS site goes live with 49 unreleased demo tracks, plus photos and notes that explain the album’s “crookedness.”

ByMaha Al-JuhaniEntertainment Correspondent, The Executives Brief
·4 min read
Lorde dumps 49 Virgin session demos on XRAYS, turning a pop anniversary into a studio teardown
Executive summary

Lorde marked the one-year anniversary of her 2025 album Virgin by publishing a personal essay and 49 demos from the album’s sessions on her new XRAYS site. For decision-makers watching creator ecosystems, it is a reminder that music marketing increasingly looks like product development, not just promotion.

Lorde is doing something most pop rollouts do not: she is letting fans hear the mess while the “official” version is already out. On Friday, for Virgin’s one-year anniversary, the singer posted a personal essay and launched a new XRAYS site that includes 49 demos from the album’s sessions, along with photos and artwork ideas.

In that essay, Lorde wrote that on “Sunday night” she realized Virgin had been out “almost a year,” and “decided something had to be done about that.” She also said sharing Virgin felt “raw and exposing in a new way,” describing how she had struggled to talk about the album since it came out. The 49-demo drop is the payoff to that framing: instead of a victory lap, it is a window into the repetitions, alternative takes, and the “crookedness” she wanted to celebrate.

The demo dump is not just quantity flexing. Several tracks show how her recording process evolved, including “Holding a Hammer,” described as a sleepy-whisper-over-bubbling-beat opener, and a deconstructed, more ethereal version of the album opener “Hammer.” She then posted four other versions of “Hammer,” each featuring slightly different musical beds and effects, turning one song into a mini exhibit of “how it got made.” That matters because it shifts the meaning of unreleased material. It is not simply bait for diehards. It becomes a narrative about experimentation, where the “studio teardown” is the story.

Lorde also contextualizes the creative grind with personal and health details. She said she was trying to heal herself during the sessions of what she described as a “brief but long-gestating eating disorder,” alongside a recent breakup and an earlier diagnosis of Premenstrual Dysphoric Disorder (PMDD), a severe form of PMS. She wrote that she “concentrated on singing to myself the way I needed to be sung to,” gradually putting music and language to “old stories” she had been scared to tell, and that she “purged them out” and felt lighter. In her words, living in these songs had an “incantatory effect,” and she felt herself change.

From a business perspective, that is not just personal catharsis. It is also a positioning choice. Lorde praises an album that inspired her, Charli xcx’s Brat, calling it “a weather system of fearlessness and fragility,” and lauds the “360” singer for keeping her “close and [giving] me the perfect amount of space.” She then includes the funky instrumental “Flux Day 2,” multiple alt versions of “What Was That,” and a trio of takes on “Chewing Gum.” The rest of the multiple-version treatment touches other Virgin tracks, including “Man of the Year,” “Current Affairs,” “Clear Blue,” “GRWM,” and “If She Could See Me Now.”

Even the language of the project pushes it beyond standard rollout. Lorde wrote about the idea of making “true X-rays of Virgin” as something “realer, funnier, more revealing of crookedness and slant,” less about where they ended up and more about “the way of travelling, the repetitions, the acne, the journey.” She also offered a sharp thesis on the work itself, saying, “Making an album is an absurd act.” She tied that absurdity to the “self-absorption and belief” required, the way you disappear into your world, always near a breakthrough, and the long stretch where the work is “really bad” and you have to “hack your way out.”

The XRAYS site mirrors that theme through visuals. It includes photos and notes, with close-ups of what Lorde described as acne that is “a thick beard going down my neck,” and a shot that appears to show her be-thonged backside peeking through skin-tone hose with a butt cut-out. There are also images of the now-29-year-old singer as a teenager, other snaps from youth dubbed “archival research,” and outtakes from the Virgin promo shoot. If Virgin debuted at No. 2 on the Billboard 200, these materials are the counterweight to the leaderboard: they turn success into process documentation.

For executives and investors tracking modern music brands, there is a second-order implication here. The album is a completed product (Virgin is Lorde’s fourth studio album), but the engagement is being extended as if it is an ongoing product lifecycle: demos as early-stage artifacts, photos and notes as user-facing metadata, and an interactive “site” as the hub. This is happening in an era where creators compete for attention across platforms, and where fans increasingly reward authenticity, access, and narrative consistency. In that world, Lorde’s move suggests that the next stage of music marketing may look less like traditional campaigns and more like curated transparency that makes the audience complicit in discovery.

If you are a board member or operator, the strategic stakes are simple: loyalty is no longer just bought with the final single. It is built with the journey you allow people to see. Lorde’s 49-demos XRAYS drop is a reminder that the most durable engagement may come from turning creative uncertainty into structured, explainable experience. For everyone else in the creator economy, that is a high bar, but also a clear signal: the teardown can be the biggest flex of all.

Executive ActionsLocked

This story's Key Insights and Take-aways are locked.

Create a free account to unlock Executive Actions for one credit.

Register to Unlock

Always free for Executives Club members. Join the Club

More in Entertainment